234 related articles for article (PubMed ID: 22522091)
1. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response.
Bauhofer O; Ruggieri A; Schmid B; Schirmacher P; Bartenschlager R
Gastroenterology; 2012 Aug; 143(2):429-38.e8. PubMed ID: 22522091
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
4. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
6. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
Erickson AK; Seiwert S; Gale M
Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
[TBL] [Abstract][Full Text] [Related]
7. High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.
Cheng M; Si Y; Niu Y; Liu X; Li X; Zhao J; Jin Q; Yang W
J Virol; 2013 Sep; 87(17):9707-18. PubMed ID: 23824794
[TBL] [Abstract][Full Text] [Related]
8. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
9. IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.
Shindo H; Maekawa S; Komase K; Miura M; Kadokura M; Sueki R; Komatsu N; Shindo K; Amemiya F; Nakayama Y; Inoue T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
J Viral Hepat; 2013 Apr; 20(4):281-9. PubMed ID: 23490373
[TBL] [Abstract][Full Text] [Related]
10. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
11. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
[TBL] [Abstract][Full Text] [Related]
12. Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro.
Castet V; Fournier C; Soulier A; Brillet R; Coste J; Larrey D; Dhumeaux D; Maurel P; Pawlotsky JM
J Virol; 2002 Aug; 76(16):8189-99. PubMed ID: 12134024
[TBL] [Abstract][Full Text] [Related]
13. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells.
Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H
Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID
J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955
[TBL] [Abstract][Full Text] [Related]
16. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
17. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
18. Effect of alpha interferon on the hepatitis C virus replicon.
Guo JT; Bichko VV; Seeger C
J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
[TBL] [Abstract][Full Text] [Related]
19. Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.
Serre SB; Krarup HB; Bukh J; Gottwein JM
J Virol; 2013 Dec; 87(23):12776-93. PubMed ID: 24049176
[TBL] [Abstract][Full Text] [Related]
20. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
